Is one or two infusions better in the first week of low-dose ketamine treatment for medication-resistant depression? A post hoc pooled analysis of randomized placebo-controlled and open-label trials
Author:
Publisher
Elsevier BV
Subject
Biological Psychiatry,Psychiatry and Mental health
Reference36 articles.
1. Treatment-resistant depression: therapeutic trends, challenges, and future directions;Al-Harbi;Patient Prefer. Adherence,2012
2. The Hamilton Depression Scale (HAM-D) and the Montgomery-Asberg Depression Scale (MADRS). A psychometric re-analysis of the European genome-based therapeutic drugs for depression study using Rasch analysis;Bech;Psychiatr. Res.,2014
3. Cytokines in clinical cancer immunotherapy;Berraondo;Br. J. Cancer,2019
4. Postnatal antioxidant and anti-inflammatory treatments prevent early ketamine-induced cortical dysfunctions in adult mice;Bove;Front. Neurosci.,2020
5. Altered peripheral blood compounds in drug-naive first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis;Cakici;Brain Behav. Immun.,2020
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment‐resistant depression: A double‐blind, randomized, placebo‐controlled trial;Psychiatry and Clinical Neurosciences;2024-08-30
2. A Randomized, Double-Blind, Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation;International Journal of Neuropsychopharmacology;2023-03-26
3. Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments;Brain, Behavior, & Immunity - Health;2022-12
4. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials;European Archives of Psychiatry and Clinical Neuroscience;2022-07-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3